Big Pharma Exploited Patent Laws to Keep Medicare Drug Prices High, Report Finds

Manufacturers of the 10 medications listed under the novel Medicare price-negotiation program exploited patent laws to keep costs high for patients, according to a new report from the watchdog group Accountable.US. The report comes nearly two years after President Joe Biden signed the Inflation Reduction Act and with it launched the historic Medicare negotiation program…

Source